XML 16 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jul. 31, 2016
Jul. 31, 2015
Cash flow used in operating activities:    
Net income $ 267,717 $ 216,004
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 16,838 17,667
Stock-based compensation 21,006 17,694
Excess tax benefits from stock-based compensation (1,131) (4,603)
Income (Loss) from Equity Method Investments (22,754) (17,080)
Distributions of earnings from unconsolidated entities 14,615 8,459
Income from distressed loans and foreclosed real estate (1,593) (7,192)
Deferred tax provision (benefit) (9,807) 19,006
Deferred tax valuation allowances 506 (1,388)
Inventory impairments and write-offs 11,353 31,279
Other Noncash Income (Expense) (669) (137)
Changes in operating assets and liabilities    
Increase in inventory (667,539) (349,674)
Origination of mortgage loans (826,058) (675,643)
Sale of mortgage loans 780,508 649,464
(Increase) decrease in restricted cash and investments (26,388) 422
(Increase) decrease in receivables, prepaid expenses and other assets (11,108) (32,451)
Increase in customer deposits 43,407 69,589
(Decrease) increase in accounts payable and accrued expenses 38,073 8,410
Increase (decrease) in income taxes payable 47,771 (61,077)
Net Cash Used in Operating Activities, Continuing Operations (325,253) (111,251)
Cash flow provided by investing activities:    
Purchase of property and equipment - net (23,280) (7,245)
Sale and redemption of marketable securities 10,000 2,000
Investment in and advances to unconsolidated entities (40,627) (39,281)
Return of investments in unconsolidated entities 34,769 34,803
Investment in distressed loans and foreclosed real estate (964) (2,096)
Return of investments in distressed loans and foreclosed real estate 34,601 23,372
Net increase in cash from purchase of joint venture interest 3,848
Net Cash Provided By Investing Activities, Continuing Operations 14,499 15,401
Cash flow (used in) provided by financing activities:    
Debt issuance costs for senior notes (35)
Proceeds from loans payable 1,756,528 1,216,094
Payments of Debt Issuance Costs Notes Payable (3,936)
Principal payments of loans payable (1,688,087) (1,043,542)
Redemption of senior notes (300,000)
Proceeds from stock-based benefit plans 5,336 35,246
Excess Tax Benefit from Share-based Compensation, Financing Activities 1,131 4,603
Purchase of treasury stock (327,612) (6,746)
(Payments) receipts related to noncontrolling interest, net 290 (1,312)
Net Cash Used in Financing Activities, Continuing Operations (256,385) (95,657)
Net decrease in cash and cash equivalents (567,139) (191,507)
Cash and cash equivalents, beginning of period 918,993 586,315
Cash and cash equivalents, end of period $ 351,854 $ 394,808